keyword
MENU ▼
Read by QxMD icon Read
search

Safety of progesterone only contraception

keyword
https://www.readbyqxmd.com/read/27082029/emergency-contraception-which-is-the-best
#1
Suneeta Mittal
INTRODUCTION: Emergency contraception is a safe and effective method to prevent an unwanted pregnancy after an unprotected or inadequately protected sexual intercourse. Several methods for emergency contraception (EC) are currently registered in many countries for use in an emergency to prevent a pregnancy following an unprotected, possibly fertile intercourse or after a contraceptive accident like condom rupture. Different methods have varying modes of action, time frame of efficacy, dosage schedule and unwanted effects...
December 2016: Minerva Ginecologica
https://www.readbyqxmd.com/read/26708301/maintenance-of-ovulation-inhibition-with-a-new-progestogen-only-pill-containing-drospirenone-after-scheduled-24-h-delays-in-pill-intake
#2
Ingrid J M Duijkers, Doris Heger-Mahn, Dominique Drouin, Enrico Colli, Sven Skouby
OBJECTIVES: Traditional progestogen-only pills (POPs) have stringent daily timing and missed pill rules that might affect contraceptive reliability. A new-generation oestrogen-free pill has been developed, containing 4-mg drospirenone with a unique regimen of 24 active treatment days followed by four placebo tablets. A previous study showed that this new drospirenone-only pill effectively inhibited ovulation. Clinical efficacy, however, can be affected by compliance, and delayed or forgotten pill intake often occurs in daily life...
April 2016: Contraception
https://www.readbyqxmd.com/read/26289789/investigational-hormone-receptor-agonists-as-ongoing-female-contraception-a-focus-on-selective-progesterone-receptor-modulators-in-early-clinical-development
#3
REVIEW
Anita L Nelson
INTRODUCTION: As efforts are made to continue to increase the safety of contraceptive methods, those without estrogen have attracted new attention. Progestin-only options are available in many delivery systems, but most cause disturbed bleeding patterns. For gynecologic patients, selective progesterone receptor modulators (SPRMs) have been approved for medical abortion, for ovulation suppression in emergency contraception, and for the treatment of heavy menstrual bleeding due to leiomyoma...
2015: Expert Opinion on Investigational Drugs
https://www.readbyqxmd.com/read/26287787/practice-bulletin-no-152-emergency-contraception
#4
REVIEW
(no author information available yet)
Emergency contraception, also known as postcoital contraception, is therapy used to prevent pregnancy after an unprotected or inadequately protected act of sexual intercourse. Common indications for emergency contraception include contraceptive failure (eg, condom breakage or missed doses of oral contraceptives) and failure to use any form of contraception (). Although oral emergency contraception was first described in the medical literature in the 1960s, the U.S. Food and Drug Administration (FDA) approved the first dedicated product for emergency contraception in 1998...
September 2015: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/26287780/practice-bulletin-summary-no-152-emergency-contraception
#5
REVIEW
(no author information available yet)
Emergency contraception, also known as postcoital contraception, is therapy used to prevent pregnancy after an unprotected or inadequately protected act of sexual intercourse. Common indications for emergency contraception include contraceptive failure (eg, condom breakage or missed doses of oral contraceptives) and failure to use any form of contraception (1-3). Although oral emergency contraception was first described in the medical literature in the 1960s, the U.S. Food and Drug Administration (FDA) approved the first dedicated product for emergency contraception in 1998...
September 2015: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/26255665/investigational-hormone-receptor-agonists-as-ongoing-female-contraception-a-focus-on-selective-progesterone-receptor-modulators-in-early-clinical-development
#6
Anita L Nelson
As efforts are made to continue to increase the safety of contraceptive methods, those without estrogen have attracted new attention. Progestin-only options are available in many delivery systems, but most cause disturbed bleeding patterns. For gynecologic patients, selective progesterone receptor modulators (SPRMs) have been approved for medical abortion, for ovulation suppression in emergency contraception, and for the treatment of heavy menstrual bleeding due to leiomyoma. Areas covered: This article discusses the role of SPRMs in controlling fertility on an ongoing basis with particular emphasis on mifepristone and ulipristal acetate (UPA), since none of the other compounds has progressed out of early Phase I - II testing...
August 8, 2015: Expert Opinion on Investigational Drugs
https://www.readbyqxmd.com/read/25924648/progesterone-or-progestogen-releasing-intrauterine-systems-for-heavy-menstrual-bleeding
#7
REVIEW
Anne Lethaby, Munawar Hussain, Josephine R Rishworth, Margaret C Rees
BACKGROUND: Heavy menstrual bleeding (HMB) is an important cause of ill health in women and it accounts for 12% of all gynaecology referrals in the UK. Heavy menstrual bleeding is clinically defined as greater than or equal to 80 mL of blood loss per menstrual cycle. However, women may complain of excessive bleeding when their blood loss is less than 80 mL. Hysterectomy is often used to treat women with this complaint but medical therapy may be a successful alternative.The intrauterine device was originally developed as a contraceptive but the addition of progestogens to these devices resulted in a large reduction in menstrual blood loss...
2015: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/25624326/depot-medroxyprogesterone-acetate-in-combination-with-a-twice-daily-lopinavir-ritonavir-based-regimen-in-hiv-infected-women-showed-effective-contraception-and-a-lack-of-clinically-significant-interactions-with-good-safety-and-tolerability-results-of-the-actg
#8
MULTICENTER STUDY
Amneris E Luque, Susan E Cohn, Jeong-Gun Park, Yoninah Cramer, Adriana Weinberg, Elizabeth Livingston, Karin L Klingman, Francesca Aweeka, D Heather Watts
We conducted an open-label, steady-state pharmacokinetic (PK) study of drug-drug interactions between depot medroxyprogesterone acetate (DMPA) and twice-daily lopinavir (LPV) plus low-dose ritonavir (RTV) (LPV/r) among 24 HIV-infected women and compared the results to those for HIV-infected women receiving DMPA while on no antiretroviral therapy or on nucleosides only (n = 14 subjects from the control arm of AIDS Clinical Trials Group [ACTG] study 5093). The objectives of the study were to address the effect of LPV/r on DMPA and to address the effect of DMPA on LPV/r therapy...
April 2015: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/24978852/novel-agents-for-the-medical-treatment-of-endometriosis
#9
REVIEW
Lieven Platteeuw, Thomas D'Hooghe
PURPOSE OF REVIEW: Current medical treatments for endometriosis-associated pain, including oral contraceptives, progestins and GnRH agonists, are partially effective and have significant side-effects. The purpose of this review is to present new hormonal and nonhormonal treatment for endometriosis. RECENT FINDINGS: At present, the ideal drug that can prevent, inhibit or stop development of endometriosis, reduce associated pain or infertility and allow conception does not exist...
August 2014: Current Opinion in Obstetrics & Gynecology
https://www.readbyqxmd.com/read/24783396/desogestrel-mini-pill-is-this-safe-in-lactating-mother
#10
Dilip Kumar Dutta, Indranil Dutta
To find out the safety, effectiveness and tolerability of using desogestrel (75 microg/day), a progesterone only pill on lactating mother, a prospective clinical study was undertaken among 200 lactating women during the period from 1st January 2010 to 13th June 2011 at Gice Clinic, Kalyani, Nadia, West Bengal. The same number of cases were taken as placebo for comparison. Desogestrel was started after six weeks of delivery for six months. Patients were reviewed at 8th, 12th, 16th, 24th weeks and one year. The very interesting results were found from the follow-up study that desogestrel (75 microg/day) did not alter the amount and composition of breast milk, pregnancy was not reported as compared to placebo...
August 2013: Journal of the Indian Medical Association
https://www.readbyqxmd.com/read/24552487/selection-of-contraceptive-therapy-for-patients-with-thrombophilia-a-review-of-the-evidence
#11
REVIEW
Whitney D Maxwell, Merna Jacob, Lisa B Spiryda, Charles L Bennett
BACKGROUND: Awareness of the contributions of thrombophilia to thrombosis-related morbidity and mortality has been growing in the last few decades. Thrombophilia is especially concerning in females seeking contraception because some types of hormonal contraception have been associated with venous thromboembolism (VTE). Clinicians face a growing need for awareness of evidence-based contraception selection for this population. METHODS: PubMed literature searches were conducted to provide a review of the literature describing contraceptive use in patients with thrombophilia...
April 2014: Journal of Women's Health
https://www.readbyqxmd.com/read/23706389/usefulness-of-progesterone-only-components-for-contraception-in-patients-with-congenital-heart-disease
#12
Antonia Pijuan-Domènech, Francesc Baró-Mariné, Mireia Rojas-Torrijos, Laura Dos-Subirà, Valle Pedrosa-Del Moral, Maria Teresa Subirana-Domènech, Maria Goya-Canino, Luis Cabero-Roura, David Garcia-Dorado, Jaume Casaldàliga-Ferrer
The objective of the study is to report the contraceptive methods used by patients with congenital heart disease (CHD) before referral to a specific preconception clinic and evaluate safety and treatment adherence of the alternative contraception method, progesterone-only component (PC), offered. Contraceptive methods in the CHD population reported included estrogen-progesterone combined contraceptives (EPCC), despite the potential risk for thromboembolism. PC has been suggested as an alternative, but, no information on its use has been reported...
August 15, 2013: American Journal of Cardiology
https://www.readbyqxmd.com/read/23560561/drug-safety-evaluation-of-desogestrel
#13
REVIEW
Carolina Scala, Umberto Leone Roberti Maggiore, Valentino Remorgida, Pier Luigi Venturini, Simone Ferrero
INTRODUCTION: Desogestrel (DSG) is a third-generation progestin. It is commonly used in various formulations for hormonal contraception including combinations with ethinyl estradiol (EE), progestin-only pill and subdermal implants. DSG is also used in menopausal patients for hormone replacement therapy (HRT). AREAS COVERED: The current manuscript aims to review the available data on safety and tolerability of DSG in oral contraception and HRT. The material included in the manuscript was searched and obtained via Medline, PubMed and EMBASE up to September 2012 using the search terms 'adverse events, side effects, tolerability' in combination with 'desogestrel and progestins'...
May 2013: Expert Opinion on Drug Safety
https://www.readbyqxmd.com/read/22415029/the-immninent-dawn-of-sprms-in-obstetrics-and-gynecology
#14
REVIEW
Nathalie Chabbert-Buffet, Axelle Pintiaux, Philippe Bouchard
Selective progesterone receptor modulators (SPRMs) have been developed since the late 70s when mifepristone was first described. They act through nuclear progesterone receptors and can have agonist or mixed agonist antagonist actions depending on the cell and tissue. Mifepristone has unique major antagonist properties allowing its use for pregnancy termination. Ulipristal acetate has been marketed in 2009 for emergency contraception and has been recently approved for preoperative myoma treatment. Further perspectives for SPRMs use include long term estrogen free contraception, endometriosis treatment...
July 25, 2012: Molecular and Cellular Endocrinology
https://www.readbyqxmd.com/read/21666089/ulipristal-acetate-for-emergency-contraception
#15
REVIEW
Sara E Snow, Stephanie N Melillo, Courtney I Jarvis
OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, and safety of data of ulipristal acetate, a new emergency contraceptive approved for use up to 120 hours after unprotected intercourse. DATA SOURCES: Articles pertaining to the topic were identified and reviewed through searches of PubMed (1994-March 2011) and clinicaltrials.gov, using the key terms ulipristal and CDB-2914. Ella approval documents were obtained and reviewed from Drugs@FDA on the Food and Drug Administration (FDA) Web site...
June 2011: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/21151688/examining-the-efficacy-safety-and-patient-acceptability-of-the-combined-contraceptive-vaginal-ring-nuvaring
#16
Devorah R Wieder, Lynn Pattimakiel
The contraceptive vaginal ring is a novel contraceptive method that offers unique advantages. Intravaginal delivery of both estrogen and progesterone allows continuous release of medication, resulting in lower systemic levels. The use of long-term combined hormonal contraception enables improved cycle control compared with progesterone-only methods. The indications and usage of the NuvaRing(®) are described along with the efficacy, tolerability, and safety. Overall, the contraceptive vaginal ring appears to be very effective, with a favorable side-effect profile, and is highly acceptable to most patients...
2010: International Journal of Women's Health
https://www.readbyqxmd.com/read/19622996/safety-of-contraceptive-method-use-among-women-with-systemic-lupus-erythematosus-a-systematic-review
#17
REVIEW
Kelly R Culwell, Kathryn M Curtis, Maria del Carmen Cravioto
OBJECTIVE: To evaluate the evidence on the safety of contraceptive method use among women with systemic lupus erythematosus (SLE). DATA SOURCES: We searched the PubMed, MEDLINE, and LILACS databases for peer-reviewed articles published from database inception through January 2009, concerning the safety of contraceptive use among women with SLE. METHODS OF STUDY SELECTION: We included studies that examined health outcomes among women using a contraceptive method after the diagnosis of SLE...
August 2009: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/19340705/the-femilis-lng-ius-contraceptive-performance-an-interim-analysis
#18
Dirk Wildemeersch, Dirk Janssens, Amaury Andrade
OBJECTIVE: To provide an update on the experience with the Femilis levonorgestrel-releasing intrauterine system (LNG-IUS) used for up to five years by parous and nulliparous women, particularly with regard to its contraceptive performance. STUDY DESIGN: An interim, open, prospective non-comparative study of the Femilis LNG-IUS releasing 20 microg of levonorgestrel/day. RESULTS: Two-hundred and eighty insertions were carried out in women with a mean age of 35...
April 2009: European Journal of Contraception & Reproductive Health Care
https://www.readbyqxmd.com/read/19340703/parenteral-administration-of-progestins-for-hormonal-replacement-therapy
#19
Anita Nath, Regine Sitruk-Ware
New options for hormonal replacement therapy (HRT) include non-oral, low-dose sustained delivery of progestins in different formulations. Since the Women's Health Initiative (WHI) study, prescription trends were observed selecting progesterone over other progestins, or delivering the progestin parenterally, in order to reach low systemic levels of the steroid. Such modalities include progesterone vaginal rings or gels, and intra-uterine systems (IUSs). When given via the transdermal and intranasal routes, the hormones are delivered systemically although the first liver impact is by-passed...
April 2009: European Journal of Contraception & Reproductive Health Care
https://www.readbyqxmd.com/read/18425871/interventions-for-emergency-contraception
#20
REVIEW
L Cheng, A M Gülmezoglu, G Piaggio, E Ezcurra, P F A Van Look
BACKGROUND: Emergency contraception is using a drug or copper intrauterine device (Cu-IUD) to prevent pregnancy shortly after unprotected intercourse. Several interventions are available for emergency contraception. Information on the comparative efficacy, safety and convenience of these methods is crucial for reproductive health care providers and the women they serve. OBJECTIVES: To determine which emergency contraceptive method following unprotected intercourse is the most effective, safe and convenient to prevent pregnancy...
April 16, 2008: Cochrane Database of Systematic Reviews
keyword
keyword
86098
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"